HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott Demarest Selected Research

CDKL5 deficiency disorder

10/2022Negative impact of insomnia and daytime sleepiness on quality of life in individuals with the cyclin-dependent kinase-like 5 deficiency disorder.
1/2022CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.
10/2021Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement.
1/2021Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder.
1/2019Severity Assessment in CDKL5 Deficiency Disorder.
10/2018Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott Demarest Research Topics

Disease

7Epilepsy (Aura)
10/2022 - 01/2019
6CDKL5 deficiency disorder
10/2022 - 10/2018
3Seizures (Absence Seizure)
01/2022 - 02/2021
2Infantile Spasms (West Syndrome)
01/2022 - 01/2022
2Drug Resistant Epilepsy
10/2021 - 10/2018
1Sleep Initiation and Maintenance Disorders (Insomnia)
10/2022
1Disorders of Excessive Somnolence (Hypersomnia)
10/2022
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2022
1Congenital Disorders of Glycosylation
01/2022
1Brain Diseases (Brain Disorder)
01/2022
1Vision Disorders (Hemeralopia)
10/2021
1Neurodevelopmental Disorders
10/2021
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
02/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2021
1Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
01/2020
1Nervous System Diseases (Neurological Disorders)
12/2019
1Mitochondrial encephalopathy
01/2019
1Movement Disorders (Movement Disorder)
01/2019

Drug/Important Bio-Agent (IBA)

5Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2022 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2022
2Adrenocorticotropic Hormone (ACTH)FDA Link
01/2022 - 01/2022
1Phenobarbital (Luminal)FDA Link
01/2022
1DolicholsIBA
01/2022
1EnzymesIBA
01/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
10/2021
1Tripeptidyl-Peptidase 1IBA
01/2020
1cerliponase alfaIBA
01/2020
1Protein Isoforms (Isoforms)IBA
12/2019
1Adenosine Triphosphatases (ATPase)IBA
12/2019
1Leucovorin (Folinic Acid)FDA Link
01/2019
1VitaminsIBA
01/2019

Therapy/Procedure

6Therapeutics
10/2022 - 01/2021
1Precision Medicine
10/2022
1Ketogenic Diet
01/2022
1Polypharmacy
01/2022
1Duration of Therapy
01/2021
1Vagus Nerve Stimulation
10/2018